NT-proBNP
Related Links
- NT-proBNP as an Effective Screening Tool for CVD in People with Diabetes
- NT-proBNP as a predictor of Cardio-renal Complications in PwD
- Safety of Rx Optimisation Post AHF Hospitalization
- The Importance of Early Diagnosis and Management of AHF
- Optimising GDMT Post AHF Discharge - APAC APSC Consensus Highlights
- Initiation of GDMT Therapy in Patients Discharged Post AHF - What are the Guardrails?
- NT-proBNP for Rapid Optimisation of GDMT in AHF Patients in Japan
- Reducing Mortality and Readmission with HF Multidisciplinary Model of Care
- Screening for Occult Heart Failure (HF) in Type 2 Diabetes Mellitus (T2DM) using NT-proBNP
- Value of biomarker in HFpEF Diagnosis
- Chinese expert consensus on the risk assessment and management of panvascular disease in patients with type 2 diabetes mellitus (2022 edition)
- Heart Failure Care Beyond City Limits: Insights from a Cardiologist
- Implementation of STRONG-HF protocol in heart failure management: an Australian perspective
- Unleashing the Power of STRONG-HF: Enabling Transformation in Heart Failure Management Across China
- Screening & Diagnosis of Heart Failure in Pre-Diabetic and Diabetic Patients
- Elevating CVD management in APAC to its Zenith- with Cardiac biomarkers
- Quantum leap in reducing rehospitalization in HF by 70-80% - How and where?
- STRONG-HF: Rapid Uptitration of Guideline Directed Medical Therapy for Heart Failure
- Guidelines Interpretation - Guidelines for the management of chronic heart failure in dialysis patients in China
- Heart failure management in Australia and the role of NT-proBNP in monitoring and treatment
- Download APAC STRONG-HF Master Pack: First-hand Insights from Prof Mebazaa on Heart Failure Treatment Monitoring
- Heart Failure Management in India - Overcoming Present Challenges
- STRONG-HF Trial highlighting benefits of treatment optimisation
- STRONG-HF: Implementation of GDMT Heart Failure Therapy & Post-discharge Heart Failure Management
- NT-proBNP and ECHO in heart failure - do they always go hand in hand?
- Value of NT-ProBNP for Treatment Monitoring in CHF
- Clinical Application NT-proBNP in CKD (Chronic Kidney Diseases) Patients with Cardiovascular Diseases
- Management of Diabetes in Japan - Can Patients Play a More Significant Role?
- T2DM Patient Support Program in Hong Kong and the Value of NT-proBNP
- Advantages of early NT-proBNP testing in patients suspected with heart failure
- NT-proBNP: Increasing Clinical Confidence in Heart Failure Management
- What is the Peptide for Life initiative?
- Heart Failure in Asia - Present Challenges and Future Strategies
- Heart Failure Prevention in T2DM - Essence of JCS/JDS joint consensus
- BNP vs NT-proBNP: An Expert View
- Impact of ARNi Therapy on Natriuretic Peptide Use